|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/50 | (2006.01) |
| A61K 38/46 | (2013.01) | ||
| A61K 38/48 | (2006.01) | ||
| A61K 38/47 | (2013.01) | ||
| A61K 38/47 | (2006.01) | ||
| A61K 38/48 | (2013.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 38/4886 | (2013.01) | ||
| A61K 38/50 | (2013.01) | ||
| C12Y 302/01017 | (2013.01) | ||
| C12Y 305/01028 | (2013.01) | ||
| A61P 31/04 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3129044 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15715243.0 |
| Date of filing the European patent application | 2015-04-08 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/057625 |
| Date | 2015-04-08 |
| (87) | Number | WO 2015/155244 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 14163927 | 2014-04-08 | EP |
| (72) |
MILLER, Stefan , DE
BRIERS, Yves , BE
LAVIGNE, Rob , BE
|
| (73) |
Lysando AG ,
Wangerbergstr. 91, 9497 Triesenberg,
LI
|
| (54) | PEPTIDOGLYCAN HYDROLASE FOR USE IN THE TREATMENT OF CHRONIC BACTERIAL INFECTIONS |
| PEPTIDOGLYCAN HYDROLASE FOR USE IN THE TREATMENT OF CHRONIC BACTERIAL INFECTIONS |